ORPHA:2869
Peutz-Jeghers syndrome
Also known as: Hamartomatous intestinal polyposis · PJS
Publications
6,649
96.2th percentile
Trials
7
Interventional, condition-specific
Researchers
1,129
Distinct authors in sample
Gene link
STK11
Definitive
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A genetic intestinal polyposis syndrome characterized by development of characteristic hamartomatous polyps throughout the gastrointestinal (GI) tract, and by mucocutaneous pigmentation. This disorder carries a considerably increased risk of GI and extra-GI malignancies.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0008280
- MeSH:D010580
- OMIM:175200
- UMLS:C0031269
- NCIT:C3324
Additional Mondo synonyms (6)
Jeghers-Peutz syndrome · Peutz Jeghers Syndrome · Peutz's syndrome · STK11-related Peutz-Jeghers syndrome · hamartomatous intestinal polyposis · polyps and spots syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — STK11
- LiteraturePresent
6,649 matched papers (2,840 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
7 matched on ClinicalTrials.gov (2 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (STK11).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
6,649
6,649 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
6,649 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
2,840 in the last 10 years · medium confidence · 96.2th percentile (publications denominator)
Phrase hits: 6,649 · MeSH hits: 0
Who's working on it?
1,129
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Wang H8 papers · 2026
Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Papers in Europe PMC - 02Wang X8 papers · 2026
Department of Pain, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Papers in Europe PMC - 03Wang L6 papers · 2026
Department of Gastroenterology, Air Force Medical Center, Beijing 100142, China.
Papers in Europe PMC - 04Li Y5 papers · 2025
Department of Pharmacy, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Papers in Europe PMC - 05Li J4 papers · 2026
Department of Pathology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai200090, China.
Papers in Europe PMC - 06Liu X4 papers · 2026
Department of Ultrasound, Air Force Medical Center, Air Force Medical University, Beijing, China.
Papers in Europe PMC - 07Liu Y4 papers · 2026
The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University, Changsha, 410007, China.
Papers in Europe PMC - 08Sakamoto H4 papers · 2026
Division of Gastroenterology, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Papers in Europe PMC - 09Zelley K4 papers · 2026
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Papers in Europe PMC - 10Zhang L4 papers · 2026
Department of Ultrasound, Air Force Medical Center, Air Force Medical University, Beijing, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
7
interventional trials for this specific condition
7 interventional trials matched this specific condition name; 2 currently recruiting in our sample.
Data as of 27 July 2026
7 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 89.9th percentile).
medium confidence · 89.9th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
7 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06722534·RECRUITING·Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome
Conditions: Peutz-Jeghers Syndrome · Celecoxib · Small Bowel Polyp·Matched via name phrase
- NCT02000089·RECRUITING·The Cancer of the Pancreas Screening-5 CAPS5)Study
Conditions: Pancreas Cancer · Peutz-Jeghers Syndrome (PJS) · Gene Mutation · Germline Mutation Carrier·Matched via name phrase
Observational and natural-history studies
9 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT03050268·RECRUITING·Familial Investigations of Childhood Cancer Predisposition
Conditions: Acute Leukemia · Adenomatous Polyposis · Adrenocortical Carcinoma · AML·Matched via name phrase
- NCT04095195·RECRUITING·Registry of Subjects at Risk of Pancreatic Cancer
Conditions: Familial Pancreatic Cancer · BRCA1 Mutation · BRCA2 Mutation · Lynch Syndrome·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Peutz-Jeghers syndrome" OR "Hamartomatous intestinal polyposis" OR "Jeghers-Peutz syndrome" OR "Peutz Jeghers Syndrome" OR "Peutz's syndrome" OR "STK11-related Peutz-Jeghers syndrome" OR "polyps and spots syndrome"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Peutz-Jeghers syndrome" OR "Hamartomatous intestinal polyposis" OR "Jeghers-Peutz syndrome" OR "Peutz Jeghers Syndrome" OR "Peutz's syndrome" OR "STK11-related Peutz-Jeghers syndrome" OR "polyps and spots syndrome"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 7 interventional · 9 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: PJS
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T21:29:20.171Z
